1 Translational Cardiovascular Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, UK.
2 Harefield Heart Science Centre, National Heart & Lung Institute, Faculty of Medicine, Imperial College London, UK.
3 Translational Cardiovascular Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, UK; Harefield Heart Science Centre, National Heart & Lung Institute, Faculty of Medicine, Imperial College London, UK. Electronic address: ken.suzuki@qmul.ac.uk.